TTRX
Financials
- Market Capitalization 283.58 M
- Employee 2
- Founded 2015
- CEO N/A
- Website www.turntherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002QTLH75
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3361 |  INDP Indaptus Therapeutics, Inc. - Common Stock | 2.60 USD | -1.14% | -4.41% | -28.18% | +36.84% | 294.43 M USD | ||
| 3384 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.71 USD | -0.54% | -3.64% | +7.85% | +53.31% | 283.68 M USD | ||
| 3404 |  MGNX MacroGenics, Inc. - Common Stock | 4.37 USD | -2.89% | -6.62% | +10.35% | +178.34% | 277.77 M USD | ||
| 3412 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.22 USD | +13.27% | +6.22% | +30.59% | +14.43% | 293.11 M USD |
Frequently asked questions about Turn Therapeutics Inc. - Common Stock
What is the Turn Therapeutics Inc. - Common Stock stock price today?
The current price of Turn Therapeutics Inc. - Common Stock (TTRX) is 9.52. Over the past 24 hours, the stock has changed by +0.53%. Follow the TTRX chart for real-time price dynamics.
What is the stock ticker of Turn Therapeutics Inc. - Common Stock?
Turn Therapeutics Inc. - Common Stock trades under the ticker TTRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Turn Therapeutics Inc. - Common Stock stock going up?
TTRX has changed by +12.93% over the last week, +54.05% over the last month, and -4.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Turn Therapeutics Inc. - Common Stock net income for the last quarter?
Turn Therapeutics Inc. - Common Stock reported net income of -970.97 K for the last quarter. The previous quarter showed 279.07 K, which means net income changed by -447.93%.
How many employees does Turn Therapeutics Inc. - Common Stock have?
As of the latest available data, Turn Therapeutics Inc. - Common Stock has 2 employees. Workforce size can provide additional context about the company's scale and operations.
What is Turn Therapeutics Inc. - Common Stock EBITDA?
Turn Therapeutics Inc. - Common Stock EBITDA is -1.01 M, and its EBITDA margin is -460.08%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Turn Therapeutics Inc. - Common Stock stock?
You can buy Turn Therapeutics Inc. - Common Stock (TTRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Turn Therapeutics Inc. - Common Stock stock?
Investing in Turn Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TTRX chart and related analysis on metatrader.com as part of your research.